ACADIA PHARMACEUTICALS INC Quarterly Amortization of Intangible Assets in USD from Q2 2016 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Acadia Pharmaceuticals Inc quarterly/annual Amortization of Intangible Assets history and growth rate from Q2 2016 to Q1 2024.
  • Acadia Pharmaceuticals Inc Amortization of Intangible Assets for the quarter ending March 31, 2024 was $5.29M.
  • Acadia Pharmaceuticals Inc annual Amortization of Intangible Assets for 2023 was $4.09M.
  • Acadia Pharmaceuticals Inc annual Amortization of Intangible Assets for 2022 was $0.000, a 100% decline from 2021.
  • Acadia Pharmaceuticals Inc annual Amortization of Intangible Assets for 2021 was $1.11M, a 25% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $5.29M +$5.29M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $738K $0 -$370K -100% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $1.11M -$62K -$369K -120% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 $1.48M $400K $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $1.48M $400K $0 0% Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $1.48M $370K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $1.48M $307K $0 0% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 $1.48M $400K $0 0% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $1.48M $400K $0 0% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $1.48M $370K $0 0% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $1.48M $307K $0 0% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $1.48M $400K $0 0% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 $1.48M $400K $0 0% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.48M $370K +$1K +0.27% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $1.48M $307K -$1K -0.33% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $1.48M $400K $0 0% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-31
Q2 2018 $1.48M $400K $0 0% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $1.48M $369K $0 0% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $1.48M $308K Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $400K +$31K +8.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $400K +$154K +62.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 $369K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q3 2016 $369K Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-07
Q2 2016 $246K Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.